Risk and uncertainty: Shifting decision making for aneuploidy screening to the first trimester of pregnancy

Genetics in Medicine

Volumn 13, Issue 5, 2011, Pages 429-436

  Farrell, Ruth M ^a   Dolgin, Natasha ^b   Flocke, Susan A ^c   Winbush, Victoria ^d   Mercer, Mary Beth ^b   Simon, Christian ^e  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CLEVELAND STATE UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

decision making; informed consent; prenatal genetic screening; uncertainty

Indexed keywords

ADULT; ANEUPLOIDY; ARTICLE; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HUMAN; PRENATAL SCREENING; QUALITATIVE ANALYSIS; RISK; UNCERTAINTY;

ADOLESCENT; ADULT; ANEUPLOIDY; DECISION MAKING; DECISION TREES; FEMALE; FOCUS GROUPS; GENETIC TESTING; HUMANS; INFORMED CONSENT; MIDDLE AGED; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; QUALITATIVE RESEARCH; RISK; UNCERTAINTY; YOUNG ADULT;

EID: 79955918621     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3182076633     Document Type: Article

References (50)

1. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109: 217-227.
2. Saller DN, Canick JA. Current methods of prenatal screening for Down syn-drome and other fetal abnormalities. Clin Obstet Gynecol 2008;51:24-36. (Pubitemid 351640160)
3. Kazerouni NN, Currier B, Malm L, et al. Triple-marker prenatal screening program for chromosomal defects. Obstet Gynecol 2009;114:50-58.
4. Driscoll DA, Gross S. Prenatal screening for aneuploidy. N Engl J Med 2009;360:2556-2562.
5. Grossman D, Blanchard K, Blumenthal P. Complications after second trimester surgical and medical abortion. Reprod Health Matters 2008;16(suppl 31): 173-182.
6. Spencer K. Aneuploidy screening in the first trimester. Am J Med Genet C Semin Med Genet 2007;145C:18-32. (Pubitemid 46427651)
7. Reddy UM, Wapner RJ. Comparison of first and second trimester aneu-ploidy risk assessment. Clin Obstet Gynecol 2007;50:442-453. (Pubitemid 46869792)
8. Driscoll DA, Gross SJ. First trimester diagnosis and screening for fetal aneuploidy. Genet Med 2008;10:73-75.
9. Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med 2003;5: 70-76. (Pubitemid 36992615)
10. Marteau TM, Dormandy E. Facilitating informed choice in prenatal testing: how well are we doing? Am J Med Genet 2001;106:185-190 (Pubitemid 32983385)
11. van den Berg M, Timmermans DR, Ten Kate LP, van Vugt JM, van der Wal G. Are pregnant women making informed choices about prenatal screening? Genet Med 2005;7:332-338. (Pubitemid 40827582)
12. Michie S, Dormandy E, Marteau TM. Informed choice: understanding knowledge in the context of screening uptake. Patient Educ Couns 2003; 50:247-253 (Pubitemid 36945295)
13. van den Berg M, Timmermans DR, ten Kate LP, van Vugt JM, van der Wal G. Informed decision making in the context of prenatal screening. Patient Educ Couns 2006;63:110-117. (Pubitemid 44331541)
14. Mulvey S, Wallace EM. Levels of knowledge of Down syndrome and Down syndrome testing in Australian women. Aust N Z J Obstet Gynaecol 2001; 41:167-169. (Pubitemid 32515015)
15. Jaques AM, Halliday JL, Bell RJ. Do women know that prenatal testing detects fetuses with Down syndrome? J Obstet Gynaecol 2004;24:647-651. (Pubitemid 39655422)
16. Malone F, Canick J, Ball R, et al. First trimester or second trimester screening, or both, for Down syndrome. N Engl J Med 2005;353:2001-2010.
17. Reedy U, Mennuti M. Incorporating first trimester Down syndrome studies into prenatal screening. Obs Gyn 2006;107:167-173.
18. Strauss A, Corbin J. Basics of qualitative research: techniques and proce-dures for developing grounded theory, 2nd ed. Thousand Oaks, CA: Sage Publications, 1998.
19. Gabbe S, Niebyl J, Simpson L, editors. Obstetrics: normal and problem pregnancies, 4th ed. Philadelphia: Elsevier Science, 2007.
20. Ohman SG, Grunewald C, Waldenstrom U. Women's worries during preg-nancy: testing the Cambridge worry scale on 200 Swedish women. Scand J Caring Sci 2003;17:148-152. (Pubitemid 36718338)
21. Muller MA, Bleker OP, Bonsel GJ, Bilardo CM. Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol 2006;27:357-361. (Pubitemid 43735472)
22. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-96. (Pubitemid 43882311)
23. Frost CJ, Venne V, Cunningham D, Gerritsen-McKane R. Decision making with uncertain information: learning from women in a high risk breast cancer clinic. J Genet Couns 2004;13:221-236. (Pubitemid 39012928)
24. Hurley KE, Miller SM, Costalas JW, Gillespie D, Daly MB. Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. J Womens Health Gend Based Med 2001;10:189-199. (Pubitemid 32243839)
25. McNally RJ. Cognitive bias in the anxiety disorders. Nebr Symp Motiv 1996;43:211-250.
26. Persson I, Thurfjell E, Bergstrom R, Holmberg L. Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening. Int J Cancer 1997; 72:758-761. (Pubitemid 27431516)
27. Leung W, Goldberg F, Zee B, Sterns E. Mammographic density in women on postmenopausal hormone replacement therapy. Surgery 1997;122:669-673.
28. Coles ME, Heimberg RG. Memory biases in the anxiety disorders: current status. Clin Psychol Rev 2002;22:587-627. (Pubitemid 34462894)
29. Chapman G, Elstein A. Cognitive processes and biases in medical decision making. In: Chapman G, Sonnenberg F, editors. Decision making in health care: theory, psychology, and applications. Cambridge: Cambridge Univer¬sity Press, 2000:183-210.
30. Watson M, Duvivier V, Wade Walsh M, et al. Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998;35:731-738. (Pubitemid 28377195)
31. Bossuyt PM, Raaymakers TW, Bonsel GJ, Rinkel GJ. Screening families for intracranial aneurysms: anxiety, perceived risk, and informed choice. Prev Med 2005;41:795-799. (Pubitemid 41400047)
32. Marteau TM, Kidd J, Cook R, et al. Perceived risk not actual risk predicts uptake of amniocentesis. Br J Obstet Gynaecol 1991;98:282-286.
33. Shiloh S, Saxe L. Perception of risk in genetic counseling. Psychol Health 1989;3:45-61.
34. Abuelo DN, Hopmann MR, Barsel-Bowers G, Goldstein A. Anxiety in women with low maternal serum alpha-fetoprotein screening results. Prenat Diagn 1991;11:381-385.
35. Marteau TM, Cook R, Kidd J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 1992;12:205-214.
36. Statham H, Green J. Serum screening for Down's syndrome: some women's experiences. BMJ 1993;307:174-176. (Pubitemid 23199983)
37. Khoshnood B, De Vigan C, Blondel B, et al. Women's interpretation of an abnormal result on measurement of fetal nuchal translucency and maternal serum screening for prenatal testing of Down syndrome. Ultrasound Obstet Gynecol 2006;28:242-248. (Pubitemid 44409048)
38. Georgsson Ohman S, Grunewald C, Waldenstrom U. Perception of risk in relation to ultrasound screening for Down syndrome during pregnancy. Midwifery 2009;25:264-276.
39. Lerner JS, Keltner D. Fear, anger, and risk. J Pers Soc Psychol 2001;81: 146-159. (Pubitemid 33594645)
40. Driscoll DA, Morgan MA, Schulkin J. Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 2009;200:459.e1-459.e9.
41. Rostant K, Steed L, O'Leary P. Prenatal screening and diagnosis: a survey of health care providers' knowledge and attitudes. Aust N Z J Obstet Gynaecol 2003;43:307-311. (Pubitemid 37069399)
42. Tyzack K, Wallace EM. Down syndrome screening: what do health profes-sionals know? Aust N Z J Obstet Gynaecol 2003;43:217-221. (Pubitemid 36790193)
43. Yankowitz J, Howser D, Ely J. Differences in practice patterns between obstetricians and family physicians: use of serum screening. Am J Obstet Gynecol 1996;174:1361-1365. (Pubitemid 26131161)
44. Cleary-Goldman J, Morgan MA, Malone FD, Robinson JN, D'Alton ME, Schulkin J. Screening for Down syndrome: practice patterns and knowledge of obstetricians and gynecologists. Obstet Gynecol 2006;107:11-17.
45. Kuppermann M, Norton ME, Gates E, et al. Computerized prenatal genetic testing decision-assisting tool: randomized controlled trial. Obstet Gynecol 2009;113:53-63.
46. Nagle C, Gunn J, Bell R, et al. Use of a decision aid for prenatal testing of fetal abnormalities to improve women's informed decision making: a cluster randomized controlled trial. BJOG 2008;115:339-347.
47. Rapp R. Testing women, testing the fetus. London: Routledge, 1999.
48. Charo RA, Rothenberg KH. "The good mother": the limits of reproductive accountability and genetic choice. In: Apple RD, Golden J, Rothenberg K, Thomson EJ, editors. Women and prenatal testing: facing the challenges of genetic technology. Columbus: Ohio State University Press, 1994:105-130.
49. Rothman BK. The tentative pregnancy: then and now. In: Apple RD, Golden J, Rothenberg KH, Thomson EJ, editors. Women and prenatal testing: facing the challenges. Columbus: Ohio State University Press, 1994:260-294.
50. Press N, Browner CH. Risk, autonomy, and responsibility: informed consent for prenatal testing. Hastings Cent Rep 1995;25(suppl 3):S9-S12.